278 related articles for article (PubMed ID: 18513743)
1. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.
Figliola R; Busanello A; Vaccarello G; Maione R
J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.
Cucciolla V; Borriello A; Criscuolo M; Sinisi AA; Bencivenga D; Tramontano A; Scudieri AC; Oliva A; Zappia V; Della Ragione F
Carcinogenesis; 2008 Mar; 29(3):560-7. PubMed ID: 18204075
[TBL] [Abstract][Full Text] [Related]
3. BMP2 and BMP6 control p57(Kip2) expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes.
Gosselet FP; Magnaldo T; Culerrier RM; Sarasin A; Ehrhart JC
Cell Signal; 2007 Apr; 19(4):731-9. PubMed ID: 17112701
[TBL] [Abstract][Full Text] [Related]
4. p57Kip2 is induced by MyoD through a p73-dependent pathway.
Vaccarello G; Figliola R; Cramerotti S; Novelli F; Maione R
J Mol Biol; 2006 Feb; 356(3):578-88. PubMed ID: 16405903
[TBL] [Abstract][Full Text] [Related]
5. MyoD induces the expression of p57Kip2 in cells lacking p21Cip1/Waf1: overlapping and distinct functions of the two cdk inhibitors.
Figliola R; Maione R
J Cell Physiol; 2004 Sep; 200(3):468-75. PubMed ID: 15254975
[TBL] [Abstract][Full Text] [Related]
6. The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region.
Andresini O; Rossi MN; Matteini F; Petrai S; Santini T; Maione R
Epigenetics Chromatin; 2019 Jan; 12(1):8. PubMed ID: 30651140
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells.
Nakano N; Urasawa K; Takagi Y; Saito T; Kaneta S; Ishikawa S; Higashi H; Tsutsui H; Hatakeyama M; Kitabatake A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1661-7. PubMed ID: 16259944
[TBL] [Abstract][Full Text] [Related]
8. The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway.
Vlachos P; Nyman U; Hajji N; Joseph B
Cell Death Differ; 2007 Aug; 14(8):1497-507. PubMed ID: 17464323
[TBL] [Abstract][Full Text] [Related]
9. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.
Vlachos P; Joseph B
Oncogene; 2009 Nov; 28(47):4175-88. PubMed ID: 19734939
[TBL] [Abstract][Full Text] [Related]
10. A cross-talk between DNA methylation and H3 lysine 9 dimethylation at the KvDMR1 region controls the induction of Cdkn1c in muscle cells.
Andresini O; Ciotti A; Rossi MN; Battistelli C; Carbone M; Maione R
Epigenetics; 2016 Nov; 11(11):791-803. PubMed ID: 27611768
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic regulation of p57kip2 by Hes/Hey downstream of Notch signaling and muscle regulatory factors regulates skeletal muscle growth arrest.
Zalc A; Hayashi S; Auradé F; Bröhl D; Chang T; Mademtzoglou D; Mourikis P; Yao Z; Cao Y; Birchmeier C; Relaix F
Development; 2014 Jul; 141(14):2780-90. PubMed ID: 25005473
[TBL] [Abstract][Full Text] [Related]
12. p57(Kip2) and cancer: time for a critical appraisal.
Borriello A; Caldarelli I; Bencivenga D; Criscuolo M; Cucciolla V; Tramontano A; Oliva A; Perrotta S; Della Ragione F
Mol Cancer Res; 2011 Oct; 9(10):1269-84. PubMed ID: 21816904
[TBL] [Abstract][Full Text] [Related]
13. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts.
Reynaud EG; Pelpel K; Guillier M; Leibovitch MP; Leibovitch SA
Mol Cell Biol; 1999 Nov; 19(11):7621-9. PubMed ID: 10523650
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the mouse CTP: phosphoethanolamine cytidylyltransferase gene Pcyt2 during myogenesis.
Zhu L; Michel V; Bakovic M
Gene; 2009 Nov; 447(1):51-9. PubMed ID: 19646513
[TBL] [Abstract][Full Text] [Related]
15. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent changes of p57(Kip2) and p21(Cip1/Waf1) expression in skeletal muscle and lung of mice.
Park CW; Chung JH
Biochim Biophys Acta; 2001 Aug; 1520(2):163-8. PubMed ID: 11513958
[TBL] [Abstract][Full Text] [Related]
17. Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.
Sirri V; Leibovitch MP; Leibovitch SA
Oncogene; 2003 Aug; 22(36):5658-66. PubMed ID: 12944914
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of MyoD by direct binding to p57(Kip2).
Reynaud EG; Leibovitch MP; Tintignac LA; Pelpel K; Guillier M; Leibovitch SA
J Biol Chem; 2000 Jun; 275(25):18767-76. PubMed ID: 10764802
[TBL] [Abstract][Full Text] [Related]
19. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene.
Tamir Y; Bengal E
Oncogene; 1998 Jul; 17(3):347-56. PubMed ID: 9690516
[TBL] [Abstract][Full Text] [Related]
20. Prox1 interacts with Atoh1 and Gfi1, and regulates cellular differentiation in the inner ear sensory epithelia.
Kirjavainen A; Sulg M; Heyd F; Alitalo K; Ylä-Herttuala S; Möröy T; Petrova TV; Pirvola U
Dev Biol; 2008 Oct; 322(1):33-45. PubMed ID: 18652815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
